33
views
0
recommends
+1 Recommend
2 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Broad betacoronavirus neutralization by a stem helix–specific human antibody

      research-article
      1 , 2 , 3 , 4 , 2 , 3 , 3 , 2 , 2 , 1 , 3 , 3 , 4 , 3 , 3 , 1 , 1 , 1 , 5 , 5 , 5 , 1 , 1 , 1 , 1 , 1 , 1 , 4 , 6 , 7 , 8 , 9 , 9 , 10 , 11 , 10 , 12 , 9 , 10 , 13 , 14 , 15 , 1 , 1 , 1 , 1 , 3 , 3 , 3 , 3 , 5 , 3 , 1 , 4 , 16 , 3 , 3 , 17 , 18 , 1 , 1 , * , , 2 , * ,
      Science (New York, N.y.)
      American Association for the Advancement of Science

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Targeting a range of betacoranaviruses

          In the past 20 years, three highly pathogenic β-coronaviruses have crossed from animals to humans, including the most recent: severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). A spike protein that decorates these viruses has an S1 domain that binds host cell receptors and an S2 domain that fuses the viral and cell membranes to allow cell entry. The S1 domain is the target of many neutralizing antibodies but is more genetically variable than S2, and antibodies can exert selective pressure, leading to resistant variants. Pinto et al. identified five monoclonal antibodies that interact with a helix in the S2 domain. The most broadly neutralizing antibody inhibited all β-coronavirus subgenera and reduced viral burden in hamsters infected with SARS-CoV-2. —VV

          Abstract

          A broadly neutralizing monoclonal antibody targeting the conserved viral spike stem helix reduces SARS-CoV-2 burden in hamsters.

          Abstract

          The spillovers of betacoronaviruses in humans and the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants highlight the need for broad coronavirus countermeasures. We describe five monoclonal antibodies (mAbs) cross-reacting with the stem helix of multiple betacoronavirus spike glycoproteins isolated from COVID-19 convalescent individuals. Using structural and functional studies, we show that the mAb with the greatest breadth (S2P6) neutralizes pseudotyped viruses from three different subgenera through the inhibition of membrane fusion, and we delineate the molecular basis for its cross-reactivity. S2P6 reduces viral burden in hamsters challenged with SARS-CoV-2 through viral neutralization and Fc-mediated effector functions. Stem helix antibodies are rare, oftentimes of narrow specificity, and can acquire neutralization breadth through somatic mutations. These data provide a framework for structure-guided design of pan-betacoronavirus vaccines eliciting broad protection.

          Related collections

          Most cited references79

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Trimmomatic: a flexible trimmer for Illumina sequence data

          Motivation: Although many next-generation sequencing (NGS) read preprocessing tools already existed, we could not find any tool or combination of tools that met our requirements in terms of flexibility, correct handling of paired-end data and high performance. We have developed Trimmomatic as a more flexible and efficient preprocessing tool, which could correctly handle paired-end data. Results: The value of NGS read preprocessing is demonstrated for both reference-based and reference-free tasks. Trimmomatic is shown to produce output that is at least competitive with, and in many cases superior to, that produced by other tools, in all scenarios tested. Availability and implementation: Trimmomatic is licensed under GPL V3. It is cross-platform (Java 1.5+ required) and available at http://www.usadellab.org/cms/index.php?page=trimmomatic Contact: usadel@bio1.rwth-aachen.de Supplementary information: Supplementary data are available at Bioinformatics online.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

            Summary The recent emergence of the novel, pathogenic SARS-coronavirus 2 (SARS-CoV-2) in China and its rapid national and international spread pose a global health emergency. Cell entry of coronaviruses depends on binding of the viral spike (S) proteins to cellular receptors and on S protein priming by host cell proteases. Unravelling which cellular factors are used by SARS-CoV-2 for entry might provide insights into viral transmission and reveal therapeutic targets. Here, we demonstrate that SARS-CoV-2 uses the SARS-CoV receptor ACE2 for entry and the serine protease TMPRSS2 for S protein priming. A TMPRSS2 inhibitor approved for clinical use blocked entry and might constitute a treatment option. Finally, we show that the sera from convalescent SARS patients cross-neutralized SARS-2-S-driven entry. Our results reveal important commonalities between SARS-CoV-2 and SARS-CoV infection and identify a potential target for antiviral intervention.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              UCSF Chimera--a visualization system for exploratory research and analysis.

              The design, implementation, and capabilities of an extensible visualization system, UCSF Chimera, are discussed. Chimera is segmented into a core that provides basic services and visualization, and extensions that provide most higher level functionality. This architecture ensures that the extension mechanism satisfies the demands of outside developers who wish to incorporate new features. Two unusual extensions are presented: Multiscale, which adds the ability to visualize large-scale molecular assemblies such as viral coats, and Collaboratory, which allows researchers to share a Chimera session interactively despite being at separate locales. Other extensions include Multalign Viewer, for showing multiple sequence alignments and associated structures; ViewDock, for screening docked ligand orientations; Movie, for replaying molecular dynamics trajectories; and Volume Viewer, for display and analysis of volumetric data. A discussion of the usage of Chimera in real-world situations is given, along with anticipated future directions. Chimera includes full user documentation, is free to academic and nonprofit users, and is available for Microsoft Windows, Linux, Apple Mac OS X, SGI IRIX, and HP Tru64 Unix from http://www.cgl.ucsf.edu/chimera/. Copyright 2004 Wiley Periodicals, Inc.
                Bookmark

                Author and article information

                Contributors
                Role: ConceptualizationRole: InvestigationRole: MethodologyRole: ResourcesRole: ValidationRole: VisualizationRole: Writing - original draftRole: Writing - review & editing
                Role: ConceptualizationRole: Formal analysisRole: Funding acquisitionRole: InvestigationRole: MethodologyRole: ValidationRole: VisualizationRole: Writing - original draftRole: Writing - review & editing
                Role: Formal analysisRole: InvestigationRole: Project administrationRole: ResourcesRole: Writing - review & editing
                Role: ConceptualizationRole: Formal analysisRole: InvestigationRole: MethodologyRole: ResourcesRole: ValidationRole: VisualizationRole: Writing - original draftRole: Writing - review & editing
                Role: ConceptualizationRole: Formal analysisRole: InvestigationRole: MethodologyRole: Project administrationRole: ValidationRole: VisualizationRole: Writing - review & editing
                Role: InvestigationRole: Validation
                Role: Formal analysisRole: InvestigationRole: MethodologyRole: ValidationRole: Visualization
                Role: InvestigationRole: Writing - review & editing
                Role: InvestigationRole: MethodologyRole: ValidationRole: Writing - review & editing
                Role: InvestigationRole: MethodologyRole: Visualization
                Role: Investigation
                Role: Formal analysisRole: Software
                Role: ConceptualizationRole: InvestigationRole: ResourcesRole: Validation
                Role: Investigation
                Role: InvestigationRole: MethodologyRole: Validation
                Role: Investigation
                Role: Investigation
                Role: Data curationRole: Formal analysisRole: InvestigationRole: MethodologyRole: Project administrationRole: ResourcesRole: ValidationRole: VisualizationRole: Writing - original draft
                Role: Formal analysisRole: InvestigationRole: MethodologyRole: Project administrationRole: SupervisionRole: ValidationRole: Writing - review & editing
                Role: ConceptualizationRole: MethodologyRole: Project administrationRole: SupervisionRole: ValidationRole: Writing - original draft
                Role: Formal analysisRole: Software
                Role: Investigation
                Role: Data curationRole: InvestigationRole: MethodologyRole: ResourcesRole: Validation
                Role: Data curationRole: Formal analysisRole: InvestigationRole: ResourcesRole: Validation
                Role: ConceptualizationRole: Formal analysisRole: InvestigationRole: MethodologyRole: ResourcesRole: ValidationRole: VisualizationRole: Writing - original draftRole: Writing - review & editing
                Role: Investigation
                Role: ConceptualizationRole: InvestigationRole: Methodology
                Role: InvestigationRole: ResourcesRole: Writing - review & editing
                Role: ConceptualizationRole: InvestigationRole: MethodologyRole: Project administrationRole: ValidationRole: Writing - original draftRole: Writing - review & editing
                Role: InvestigationRole: Project administrationRole: ResourcesRole: Supervision
                Role: ConceptualizationRole: Data curationRole: Funding acquisitionRole: InvestigationRole: MethodologyRole: Project administrationRole: Resources
                Role: VisualizationRole: Writing - review & editing
                Role: Resources
                Role: Resources
                Role: Formal analysisRole: InvestigationRole: ResourcesRole: ValidationRole: Visualization
                Role: ConceptualizationRole: InvestigationRole: Project administrationRole: Resources
                Role: ConceptualizationRole: Data curationRole: InvestigationRole: MethodologyRole: ResourcesRole: SupervisionRole: Validation
                Role: ConceptualizationRole: Data curationRole: Project administrationRole: ResourcesRole: Supervision
                Role: Project administrationRole: ResourcesRole: Supervision
                Role: Project administrationRole: Resources
                Role: ConceptualizationRole: Data curationRole: Formal analysisRole: InvestigationRole: MethodologyRole: Project administrationRole: ResourcesRole: SoftwareRole: SupervisionRole: ValidationRole: Visualization
                Role: InvestigationRole: MethodologyRole: Project administrationRole: ResourcesRole: SupervisionRole: ValidationRole: VisualizationRole: Writing - original draftRole: Writing - review & editing
                Role: ConceptualizationRole: Formal analysisRole: InvestigationRole: MethodologyRole: Project administrationRole: ResourcesRole: SupervisionRole: ValidationRole: VisualizationRole: Writing - original draftRole: Writing - review & editing
                Role: ResourcesRole: Validation
                Role: Writing - original draftRole: Writing - review & editing
                Role: ConceptualizationRole: Funding acquisitionRole: MethodologyRole: Project administrationRole: SupervisionRole: ValidationRole: Writing - review & editing
                Role: ConceptualizationRole: Formal analysisRole: Project administrationRole: VisualizationRole: Writing - original draftRole: Writing - review & editing
                Role: ConceptualizationRole: Funding acquisitionRole: MethodologyRole: Project administrationRole: SupervisionRole: ValidationRole: Writing - original draftRole: Writing - review & editing
                Role: ConceptualizationRole: Formal analysisRole: Project administrationRole: ResourcesRole: ValidationRole: VisualizationRole: Writing - original draftRole: Writing - review & editing
                Role: ConceptualizationRole: Funding acquisitionRole: MethodologyRole: Project administrationRole: SupervisionRole: ValidationRole: VisualizationRole: Writing - original draftRole: Writing - review & editing
                Role: ConceptualizationRole: Formal analysisRole: Funding acquisitionRole: MethodologyRole: Project administrationRole: ResourcesRole: SupervisionRole: ValidationRole: VisualizationRole: Writing - original draft
                Journal
                Science
                Science
                science
                Science (New York, N.y.)
                American Association for the Advancement of Science
                0036-8075
                1095-9203
                03 September 2021
                03 August 2021
                03 August 2021
                : 373
                : 6559
                : 1109-1116
                Affiliations
                [1 ]Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland.
                [2 ]Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.
                [3 ]Vir Biotechnology, San Francisco, CA 94158, USA.
                [4 ]Institute for Research in Biomedicine, Università della Svizzera italiana, 6500 Bellinzona, Switzerland.
                [5 ]Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, KU Leuven, 3000 Leuven, Belgium.
                [6 ]Clinical Trial Unit, Ente Ospedaliero Cantonale, 6900 Lugano, Switzerland.
                [7 ]Division of Clinical Pharmacology and Toxicology, Institute of Pharmacological Sciences of Southern Switzerland, Ente Ospedaliero Cantonale, 6900 Lugano, Switzerland.
                [8 ]Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, 8091 Zurich, Switzerland.
                [9 ]Faculty of Biomedical Sciences, Università della Svizzera italiana, 6900 Lugano, Switzerland.
                [10 ]Department of Medicine, Ente Ospedaliero Cantonale, 6500 Bellinzona, Switzerland.
                [11 ]Clinical School, University of New South Wales, Sydney, NSW, 2052, Australia.
                [12 ]Faculty of Medicine, University of Zurich, 8057 Zurich, Switzerland.
                [13 ]Intensive Care Unit, Clinica Luganese Moncucco, 6900 Lugano, Switzerland.
                [14 ]Clinic of Internal Medicine and Infectious Diseases, Clinica Luganese Moncucco, 6900 Lugano, Switzerland.
                [15 ]III Division of Infectious Diseases, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, 20157 Milan, Italy.
                [16 ]Institute of Microbiology, ETH Zurich, 8093 Zurich, Switzerland.
                [17 ]UT Southwestern Medical Center, Dallas, TX 75390, USA.
                [18 ]Washington University School of Medicine, St. Louis, MO 63110, USA.
                Author notes
                [* ]Corresponding author. Email: dveesler@ 123456uw.edu (D.V.); dcorti@vir.bio (D.C.)
                [†]

                These authors contributed equally to this work.

                Author information
                https://orcid.org/0000-0003-0908-0775
                https://orcid.org/0000-0002-3146-4110
                https://orcid.org/0000-0002-1775-0778
                https://orcid.org/0000-0002-2260-2577
                https://orcid.org/0000-0002-9113-8181
                https://orcid.org/0000-0002-9636-8330
                https://orcid.org/0000-0003-3590-9727
                https://orcid.org/0000-0003-3759-3252
                https://orcid.org/0000-0002-8030-0219
                https://orcid.org/0000-0001-9343-127X
                https://orcid.org/0000-0001-5358-5055
                https://orcid.org/0000-0002-3991-7401
                https://orcid.org/0000-0003-3258-5552
                https://orcid.org/0000-0002-0956-0018
                https://orcid.org/0000-0001-9771-7312
                https://orcid.org/0000-0002-6380-4917
                https://orcid.org/0000-0002-7888-4534
                https://orcid.org/0000-0003-3360-1999
                https://orcid.org/0000-0002-5100-8905
                https://orcid.org/0000-0002-4723-6892
                https://orcid.org/0000-0001-6025-6735
                https://orcid.org/0000-0001-8674-4294
                https://orcid.org/0000-0002-4308-0405
                https://orcid.org/0000-0002-9619-3104
                https://orcid.org/0000-0003-2306-0498
                https://orcid.org/0000-0003-4146-3434
                https://orcid.org/0000-0002-0832-2376
                https://orcid.org/0000-0003-3171-3049
                https://orcid.org/0000-0002-1974-5606
                Article
                abj3321
                10.1126/science.abj3321
                9268357
                34344823
                37ba9895-a6c2-4f96-a016-bb15629f3620
                Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution License 4.0 (CC BY).

                This is an open-access article distributed under the terms of the Creative Commons Attribution license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 06 May 2021
                : 29 July 2021
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/100000002, National Institutes of Health;
                Funded by: FundRef http://dx.doi.org/10.13039/100000015, U.S. Department of Energy;
                Award ID: DE-AC02-76SF00515
                Funded by: FundRef http://dx.doi.org/10.13039/100000015, U.S. Department of Energy;
                Award ID: P30GM133894
                Funded by: FundRef http://dx.doi.org/10.13039/100000057, National Institute of General Medical Sciences;
                Funded by: FundRef http://dx.doi.org/10.13039/100000060, National Institute of Allergy and Infectious Diseases;
                Award ID: DP1AI158186
                Funded by: FundRef http://dx.doi.org/10.13039/100000060, National Institute of Allergy and Infectious Diseases;
                Award ID: HHSN272201700059C
                Funded by: FundRef http://dx.doi.org/10.13039/100000060, National Institute of Allergy and Infectious Diseases;
                Award ID: U01 AI151698-01
                Funded by: FundRef http://dx.doi.org/10.13039/501100002066, GlaxoSmithKline foundation;
                Award ID: V2 CHO-K1
                Funded by: FundRef http://dx.doi.org/10.13039/501100001711, Swiss National Science Foundation;
                Award ID: P400PB
                Funded by: FundRef http://dx.doi.org/10.13039/501100001711, Swiss National Science Foundation;
                Award ID: 183942
                Categories
                Research Article
                Research Articles
                R-Articles
                Biochem
                Microbio
                Coronavirus
                Custom metadata
                5
                5

                Uncategorized
                Uncategorized

                Comments

                Comment on this article